Stock Analysis

What Is Xebec Adsorption Inc.'s (CVE:XBC) Share Price Doing?

TSX:XBC
Source: Shutterstock

Xebec Adsorption Inc. (CVE:XBC), which is in the machinery business, and is based in Canada, saw a significant share price rise of over 20% in the past couple of months on the TSXV. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, could the stock still be trading at a relatively cheap price? Today I will analyse the most recent data on Xebec Adsorption’s outlook and valuation to see if the opportunity still exists.

Check out our latest analysis for Xebec Adsorption

Advertisement

Is Xebec Adsorption still cheap?

Good news, investors! Xebec Adsorption is still a bargain right now. My valuation model shows that the intrinsic value for the stock is CA$5.51, but it is currently trading at CA$3.75 on the share market, meaning that there is still an opportunity to buy now. What’s more interesting is that, Xebec Adsorption’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What does the future of Xebec Adsorption look like?

TSXV:XBC Past and Future Earnings June 18th 2020
TSXV:XBC Past and Future Earnings June 18th 2020

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to more than double in the upcoming, the future appears to be extremely bright for Xebec Adsorption. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? Since XBC is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on XBC for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy XBC. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Xebec Adsorption. You can find everything you need to know about Xebec Adsorption in the latest infographic research report. If you are no longer interested in Xebec Adsorption, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.

About TSX:XBC

Xebec Adsorption

Designs, manufactures, and sells purification, separation, dehydration, and filtration equipment for gases and compressed air in Canada, the United States, China, Korea, Italy, France, and internationally.

Flawless balance sheet and fair value.

Advertisement